SEARCH

SEARCH BY CITATION

References

  • Allen G. and Courchesne E. (2003) Differential effects of developmental cerebellar abnormality on cognitive and motor functions in the cerebellum: an fMRI study of autism. Am. J. Psychiatry 160, 262273.
  • Asperger H. (1944) Die autistischen psychopathen' im kindersalter. Arch. Psychiatr. Nervenkr. 117, 76136.
  • Bambini-Junior V., Rodrigues L., Behr G. A., Moreira J. C., Riesgo R. and Gottfried C. (2011) Animal model of autism induced by prenatal exposure to valproate: behavioral changes and liver parameters. Brain Res. 1408, 816.
  • Baron-Cohen S. (2002) The extreme male brain theory of autism. Trends Cogn. Sci. 6, 248254.
  • Baron-Cohen S. (2010) Empathizing, systemizing, and the extreme male brain theory of autism. Prog. Brain Res. 186, 167175.
  • Baron-Cohen S., Lombardo M. V., Auyeung B., Ashwin E., Chakrabarti B. and Knickmeyer R. (2011) Why are autism spectrum conditions more prevalent in males? PLoS Biol. 9, e1001081.
  • Bauman M. and Kemper T. L. (1985) Histoanatomic observations of the brain in early infantile autism. Neurology 35, 866874.
  • Bjerkedal T., Czeizel A., Goujard J., Kallen B., Mastroiacova P., Nevin N., Oakley G. Jr and Robert E. (1982) Valproic acid and spina bifida. Lancet 2, 1096.
  • Blatt G. J., Fitzgerald C. M., Guptill J. T., Booker A. B., Kemper T. L. and Bauman M. L. (2001) Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study. J. Autism Dev. Disord. 31, 537543.
  • Browning R. A., Wang C., Lanker M. L. and Jobe P. C. (1990) Electroshock- and pentylenetetrazol-induced seizures in genetically epilepsy-prone rats (GEPRs): differences in threshold and pattern. Epilepsy Res. 6, 111.
  • Bryson S. E., Clark B. S. and Smith I. M. (1988) First report of a Canadian epidemiological study of autistic syndromes. J. Child Psychol. Psychiatry 29, 433445.
  • Casanova M. F., Buxhoeveden D. P. and Brown C. (2002) Clinical and macroscopic correlates of minicolumnar pathology in autism. J. Child Neurol. 17, 692695.
  • Chez M. G., Burton Q., Dowling T., Chang M., Khanna P. and Kramer C. (2007) Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability. J. Child Neurol. 22, 574579.
  • Christianson A. L., Chesler N. and Kromberg J. G. (1994) Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs. Dev. Med. Child Neurol. 36, 361369.
  • Courchesne E., Yeung-Courchesne R., Press G. A., Hesselink J. R. and Jernigan T. L. (1988) Hypoplasia of cerebellar vermal lobules VI and VII in autism. N. Engl. J. Med. 318, 13491354.
  • Courchesne E., Saitoh O., Yeung-Courchesne R., Press G. A., Lincoln A. J., Haas R. H. and Schreibman L. (1994) Abnormality of cerebellar vermian lobules VI and VII in patients with infantile autism: identification of hypoplastic and hyperplastic subgroups with MR imaging. AJR Am. J. Roentgenol. 162, 123130.
  • Crawley J. N. (2004) Designing mouse behavioral tasks relevant to autistic-like behaviors. Ment. Retard. Dev. Disabil. Res. Rev. 10, 248258.
  • Dalens B., Raynaud E. J. and Gaulme J. (1980) Teratogenicity of valproic acid. J. Pediatr. 97, 332333.
  • Dani V. S., Chang Q., Maffei A., Turrigiano G. G., Jaenisch R. and Nelson S. B. (2005) Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome. Proc. Natl Acad. Sci. USA 102, 1256012565.
  • Derry J. M., Dunn S. M. and Davies M. (2004) Identification of a residue in the gamma-aminobutyric acid type A receptor alpha subunit that differentially affects diazepam-sensitive and -insensitive benzodiazepine site binding. J. Neurochem. 88, 14311438.
  • Fatemi S. H., Halt A. R., Stary J. M., Kanodia R., Schulz S. C. and Realmuto G. R. (2002) Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol. Psychiatry 52, 805810.
  • Fatemi S. H., Folsom T. D., Reutiman T. J. and Thuras P. D. (2009) Expression of GABA(B) receptors is altered in brains of subjects with autism. Cerebellum 8, 6469.
  • Foley A. G., Gannon S., Rombach-Mullan N., Prendergast A., Barry C., Cassidy A. W. and Regan C. M. (2012) Class I histone deacetylase inhibition ameliorates social cognition and cell adhesion molecule plasticity deficits in a rodent model of autism spectrum disorder. Neuropharmacology 63, 750760.
  • Fukuchi M., Nii T., Ishimaru N., Minamino A., Hara D., Takasaki I., Tabuchi A. and Tsuda M. (2009) Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions. Neurosci. Res. 65, 3543.
  • Geller A. M., Oshiro W. M., Haykal-Coates N., Kodavanti P. R. and Bushnell P. J. (2001) Gender-dependent behavioral and sensory effects of a commercial mixture of polychlorinated biphenyls (Aroclor 1254) in rats. Toxicol. Sci. 59, 268277.
  • Geschwind D. H. and Levitt P. (2007) Autism spectrum disorders: developmental disconnection syndromes. Curr. Opin. Neurobiol. 17, 103111.
  • Gillberg C., Cederlund M., Lamberg K. and Zeijlon L. (2006) Brief report: “the autism epidemic”. The registered prevalence of autism in a Swedish urban area. J. Autism Dev. Disord. 36, 429435.
  • Gogolla N., Leblanc J. J., Quast K. B., Sudhof T. C., Fagiolini M. and Hensch T. K. (2009) Common circuit defect of excitatory-inhibitory balance in mouse models of autism. J. Neurodev. Disord. 1, 172181.
  • Hughes J. R. and Melyn M. (2005) EEG and seizures in autistic children and adolescents: further findings with therapeutic implications. Clin. EEG Neurosci. 36, 1520.
  • Hutsler J. J. and Zhang H. (2010) Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders. Brain Res. 1309, 8394.
  • Ingram J. L., Peckham S. M., Tisdale B. and Rodier P. M. (2000) Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicol. Teratol. 22, 319324.
  • Kanner L. (1943) Autistic disturbances of affective contact. Nerv. Child 2, 217250.
  • Kataoka S., Takuma K., Hara Y., Maeda Y., Ago Y. and Matsuda T. (2011) Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid. Int. J. Neuropsychopharmacol. 16, 91103.
  • Kientz M. A. and Dunn W. (1997) A comparison of the performance of children with and without autism on the Sensory Profile. Am. J. Occup. Ther. 51, 530537.
  • Kim K. C., Kim P., Go H. S., Choi C. S., Yang S. I., Cheong J. H., Shin C. Y. and Ko K. H. (2011a) The critical period of valproate exposure to induce autistic symptoms in Sprague-Dawley rats. Toxicol. Lett. 201, 137142.
  • Kim Y. S., Leventhal B. L., Koh Y. J., et al. (2011b) Prevalence of autism spectrum disorders in a total population sample. Am. J. Psychiatry 168, 904912.
  • Langer B., Haddad J., Gasser B., Maubert M. and Schlaeder G. (1994) Isolated fetal bilateral radial ray reduction associated with valproic acid usage. Fetal Diagn. Ther. 9, 155158.
  • Litchfield J. T. Jr and Wilcoxon F. (1949) A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96, 99113.
  • Lloyd K. G., Bossi L., Morselli P. L., Munari C., Rougier M. and Loiseau H. (1986) Alterations of GABA-mediated synaptic transmission in human epilepsy. Adv. Neurol. 44, 10331044.
  • Mandy W., Chilvers R., Chowdhury U., Salter G., Seigal A. and Skuse D. (2012) Sex differences in autism spectrum disorder: evidence from a large sample of children and adolescents. J. Autism Dev. Disord. 42, 13041313.
  • Mehta M. V., Gandal M. J. and Siegel S. J. (2011) mGluR5-antagonist mediated reversal of elevated stereotyped, repetitive behaviors in the VPA model of autism. PLoS ONE 6, e26077.
  • Moore S. J., Turnpenny P., Quinn A., Glover S., Lloyd D. J., Montgomery T. and Dean J. C. (2000) A clinical study of 57 children with fetal anticonvulsant syndromes. J. Med. Genet. 37, 489497.
  • Mychasiuk R., Richards S., Nakahashi A., Kolb B. and Gibb R. (2012) Effects of rat prenatal exposure to valproic acid on behaviour and neuro-anatomy. Dev. Neurosci. 34, 268276.
  • Narita N., Kato M., Tazoe M., Miyazaki K., Narita M. and Okado N. (2002) Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: putative animal models for autism. Pediatr. Res. 52, 576579.
  • Oblak A. L., Gibbs T. T. and Blatt G. J. (2011) Reduced GABAA receptors and benzodiazepine binding sites in the posterior cingulate cortex and fusiform gyrus in autism. Brain Res. 1380, 218228.
  • Park H. G., Yoon S. Y., Choi J. Y., et al. (2007) Anticonvulsant effect of wogonin isolated from Scutellaria baicalensis. Eur. J. Pharmacol. 574, 112119.
  • Pierce K. and Courchesne E. (2001) Evidence for a cerebellar role in reduced exploration and stereotyped behavior in autism. Biol. Psychiatry 49, 655664.
  • Rinaldi T., Kulangara K., Antoniello K. and Markram H. (2007) Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid. Proc. Natl Acad. Sci. USA 104, 1350113506.
  • Ritvo E. R., Freeman B. J., Scheibel A. B., Duong T., Robinson H., Guthrie D. and Ritvo A. (1986) Lower Purkinje cell counts in the cerebella of four autistic subjects: initial findings of the UCLA-NSAC Autopsy Research Report. Am. J. Psychiatry 143, 862866.
  • Roegge C. S., Seo B. W., Crofton K. M. and Schantz S. L. (2000) Gestational-lactational exposure to Aroclor 1254 impairs radial-arm maze performance in male rats. Toxicol. Sci. 57, 121130.
  • Rubenstein J. L. and Merzenich M. M. (2003) Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav. 2, 255267.
  • Samaco R. C., Hogart A. and LaSalle J. M. (2005) Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum. Mol. Genet. 14, 483492.
  • Sandhya T., Sowjanya J. and Veeresh B. (2012) Bacopa monniera (L.) Wettst ameliorates behavioral alterations and oxidative markers in sodium valproate induced autism in rats. Neurochem. Res. 37, 11211131.
  • Sato D., Lionel A. C., Leblond C. S., et al. (2012) SHANK1 deletions in males with autism spectrum disorder. Am. J. Hum. Genet. 90, 879887.
  • Schneider T. and Przewlocki R. (2005) Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology 30, 8089.
  • Schneider T., Roman A., Basta-Kaim A., Kubera M., Budziszewska B., Schneider K. and Przewlocki R. (2008) Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid. Psychoneuroendocrinology 33, 728740.
  • Scott J. A., Schumann C. M., Goodlin-Jones B. L. and Amaral D. G. (2009) A comprehensive volumetric analysis of the cerebellum in children and adolescents with autism spectrum disorder. Autism Res. 2, 246257.
  • Sherwin A. L. and van Gelder N. M. (1986) Amino acid and catecholamine markers of metabolic abnormalities in human focal epilepsy. Adv. Neurol. 44, 10111032.
  • Shinohe A., Hashimoto K., Nakamura K., et al. (2006) Increased serum levels of glutamate in adult patients with autism. Prog. Neuropsychopharmacol. Biol. Psychiatry 30, 14721477.
  • Szatmari P., Liu X. Q., Goldberg J., Zwaigenbaum L., Paterson A. D., Woodbury-Smith M., Georgiades S., Duku E. and Thompson A. (2012) Sex differences in repetitive stereotyped behaviors in autism: implications for genetic liability. Am. J. Med. Genet. B Neuropsychiatr. Genet. 159B, 512.
  • Toro R., Konyukh M., Delorme R., et al. (2010) Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends Genet. 26, 363372.
  • Vorhees C. V. (1987a) Behavioral teratogenicity of valproic acid: selective effects on behavior after prenatal exposure to rats. Psychopharmacology 92, 173179.
  • Vorhees C. V. (1987b) Teratogenicity and developmental toxicity of valproic acid in rats. Teratology 35, 195202.
  • Wang C. C., Chen P. S., Hsu C. W., Wu S. J., Lin C. T. and Gean P. W. (2012) Valproic acid mediates the synaptic excitatory/inhibitory balance through astrocytes–a preliminary study. Prog. Neuropsychopharmacol. Biol. Psychiatry 37, 111120.
  • Wegner C. and Nau H. (1991) Diurnal variation of folate concentrations in mouse embryo and plasma: the protective effect of folinic acid on valproic-acid-induced teratogenicity is time dependent. Reprod. Toxicol. 5, 465471.
  • Wei H., Dobkin C., Sheikh A. M., Malik M., Brown W. T. and Li X. (2012) The therapeutic effect of memantine through the stimulation of synapse formation and dendritic spine maturation in autism and fragile X syndrome. PLoS ONE 7, e36981.
  • Williams R. S., Hauser S. L., Purpura D. P., DeLong G. R. and Swisher C. N. (1980) Autism and mental retardation: neuropathologic studies performed in four retarded persons with autistic behavior. Arch. Neurol. 37, 749753.
  • Zahn-Waxler C., Shirtcliff E. A. and Marceau K. (2008) Disorders of childhood and adolescence: gender and psychopathology. Annu. Rev. Clin. Psychol. 4, 275303.